Jury says Apple owes Masimo $634M for patent infringement

Core Points - A federal jury in California ruled that Apple must pay Masimo $634 million for infringing a patent related to blood oxygen monitoring technology [1] - Masimo expressed that this ruling is a significant win for protecting their innovations and intellectual property [2] - Apple plans to appeal the verdict, arguing that the patent in question expired in 2022 and pertains to outdated technology [2] - The legal dispute centers around pulse oximetry technology, with Masimo accusing Apple of hiring its employees and infringing on its patents [3] - The U.S. International Trade Commission previously sided with Masimo, banning Apple from importing Apple Watches with blood oxygen monitoring features [3] - Apple announced a new version of the blood oxygen feature that circumvents the ban by calculating readings on the paired iPhone instead of the Apple Watch [6] - Masimo is suing U.S. Customs and Border Patrol for allowing the import of Apple Watches with the new implementation [6] - Apple countersued Masimo and won a nominal payment of $250 for design patent violations [7]